• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[REVELA13观察站:研究罗讷河口省女性膀胱肿瘤新病例]

[The REVELA13 observatory to study new cases of bladder tumor among women living in Bouches-du-Rhône county].

作者信息

Martin T, Mantey K, Boissier R, Albert P, Grisoni V, Lechevallier E, Barriol D, Gravis G, Pignot G, Rossi D, Lorca J, Rattier C, Eghazarian C, Daou N, Davin J L, Clément C, Akiki A, Pascal L, Karsenty G

机构信息

Service d'urologie et de transplantation rénale, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France; Service d'urologie, hôpital Edmond Garcin, 13400 Aubagne, France.

Observatoire régional d'épidémiologie pour la région PACA, 13005 Marseille, France.

出版信息

Prog Urol. 2018 Dec;28(16):935-941. doi: 10.1016/j.purol.2018.09.004. Epub 2018 Oct 10.

DOI:10.1016/j.purol.2018.09.004
PMID:30316672
Abstract

INTRODUCTION

The REVELA13 observatory is a unique epidemiological tool listing the new cases of kidney tumors, bladder tumors and acute leukaemias in the Bouches-du-Rhône county (France). Aim was to exploit for the first time data from this observatory regarding new cases of bladder tumors≥T1 in women from 2012 to 2014.

MATERIALS

This epidemiological study was observational and descriptive. Fifteen non-nominative variables from the REVELA13 database were analyzed in order to describe the clinical and pathological characteristics of the incident cases as well as their spatial and temporal distribution. The incidence rates expressed in new cases per year per 100000 inhabitants were standardized on the world age, calculated with 95 % confidence intervals and compared to national estimates for the same period.

RESULTS

Incident bladder tumor cases were recorded in 291 women, corresponding to a standardized incidence on the world age of 3.85 [3.32-4.37] new cases per year per 100,000 population, 54 % higher than the national estimates of 2012 and 2015. Median age of diagnostic was 75.9 years. Sex ratio was 19.41 % (W/M). Tumors were predominantly non-muscle-invasive (52 %), high grade (69 %) and without associated carcinoma in situ (Cis) (49 %). The two most affected territories were Marseille and Aubagne-La Ciotat.

CONCLUSION

The REVELA13 observatory has improved our epidemiological knowledge on female bladder tumors in Bouches-du-Rhône county and highlighted a local over incidence.

LEVEL OF EVIDENCE

摘要

引言

REVELA13监测站是一种独特的流行病学工具,用于记录法国罗讷河口省肾肿瘤、膀胱肿瘤和急性白血病的新发病例。目的是首次利用该监测站2012年至2014年期间女性膀胱肿瘤≥T1新发病例的数据。

材料

本流行病学研究为观察性和描述性研究。分析了REVELA13数据库中的15个非命名变量,以描述发病病例的临床和病理特征及其时空分布。发病率以每10万居民每年的新发病例数表示,并根据世界年龄进行标准化,计算95%置信区间,并与同期的全国估计数进行比较。

结果

记录了291例女性膀胱肿瘤发病病例,世界年龄标准化发病率为每10万人口每年3.85例[3.32-4.37],比2012年和2015年的全国估计数高54%。诊断时的中位年龄为75.9岁。性别比为19.41%(女性/男性)。肿瘤主要为非肌层浸润性(52%)、高级别(69%)且无原位癌(Cis)(49%)。受影响最严重的两个地区是马赛和奥巴涅-拉乔塔。

结论

REVELA13监测站提高了我们对罗讷河口省女性膀胱肿瘤的流行病学认识,并突出了当地发病率过高的情况。

证据级别

3级。

相似文献

1
[The REVELA13 observatory to study new cases of bladder tumor among women living in Bouches-du-Rhône county].[REVELA13观察站:研究罗讷河口省女性膀胱肿瘤新病例]
Prog Urol. 2018 Dec;28(16):935-941. doi: 10.1016/j.purol.2018.09.004. Epub 2018 Oct 10.
2
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
3
[Bladder tumors in the Hérault department: Results of the Hérault tumor registry registration from1987 to 2019].
Prog Urol. 2023 Dec;33(15-16):974-982. doi: 10.1016/j.purol.2023.08.015. Epub 2023 Aug 28.
4
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
5
Bladder cancer in Spain 2011: population based study.西班牙 2011 年膀胱癌发病情况:基于人群的研究
J Urol. 2014 Feb;191(2):323-8. doi: 10.1016/j.juro.2013.08.049. Epub 2013 Aug 28.
6
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.根据日本登记膀胱癌患者的数据得出的Ta、T1期非肌层浸润性膀胱癌肿瘤复发的临床结果:日本泌尿外科学会1999 - 2001年报告
Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.
7
[Incidence of bladder cancer in France: trends from 1980 to 2000].[法国膀胱癌发病率:1980年至2000年的趋势]
Prog Urol. 2003 Sep;13(4):602-7.
8
Hospital discharges and mortality registries: 2 complementary databases for the epidemiological surveillance of stroke.医院出院和死亡率登记册:用于中风流行病学监测的 2 个互补数据库。
J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e441-5. doi: 10.1016/j.jstrokecerebrovasdis.2013.04.039. Epub 2013 Jun 2.
9
[Departmental compilation of histoprognostic data in senology. Apropos of campaign screening in Bouches-du-Rhône].
Bull Cancer. 1992;79(10):999-1008.
10
Estimating infra-national and national thyroid cancer incidence in France from cancer registries data and national hospital discharge database.利用癌症登记数据和国家医院出院数据库估算法国国内及全国范围内的甲状腺癌发病率。
Eur J Epidemiol. 2007;22(9):607-14. doi: 10.1007/s10654-007-9158-6. Epub 2007 Jul 18.